01
Cash & equivalents increased 453.4%
Cash & equivalents changed +453.4% from the comparable as-filed period.
$4.3M→$24.0MComparable → current
· Biological Products, (No Diagnostic Substances)
RESEARCH SNAPSHOTArmata Pharmaceuticals, Inc.'s latest supported as-filed period reports net income of $74.1M, 555.0% above the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +453.4% from the comparable as-filed period.
Net income changed +555.0% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Operating income changed -50.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
ARMP · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001104659-26-094907SEC ↗8-KAug 12, 2026Period Aug 12, 20260001104659-26-094896SEC ↗8-KJul 20, 2026Period Jul 20, 20260001104659-26-084861SEC ↗8-KJul 20, 2026Period Jul 17, 20260001104659-26-084860SEC ↗4Jul 14, 2026Period Jul 10, 20260001104659-26-083516SEC ↗8-KJul 13, 2026Period Jul 13, 20260001104659-26-082850SEC ↗8-K/AJun 24, 2026Period Apr 24, 20260001104659-26-077313SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jul 10, 2026Filed Jul 14, 2026 | Birx DeborahChief Executive Officer | Tax WithholdingDirect | 14,041 | $4 | $59,815 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Stock-based compensation changed +489.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001104659-26-076627